OxyContin Sales Data

Rank 19 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows OxyContin U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 19 -2.91% -1.87%
Q3 2013 19 (2) -3.01% -3.52%
Q2 2013 17 (2) -4.71% -5.87%
Q1 2013 15 (1) -2.38% -5.47%
Q4 2012 14 (1) -1.69% -0.72%
Q3 2012 13 (2) -0.55% 0.16%
Q2 2012 15 (3) 3.14% 0.16%
Q1 2012 18 (1) -1.05% -2.35%
Q4 2011 17 (2) -2.58% -1.69%
Q3 2011 19 (2) -5.33% -4.69%
Q2 2011 17 2.82% -1.02%
Q1 2011 17

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
July 14, 2014Popping Pills in America: Can the DEA Fix This?
April 17, 2013Purdue Pharma Statement on FDA Approval of New Label for Reformulated OxyContin and FDA Decision Regarding Withdrawal of Original Formulation Due to Safety
August 1, 2011When Teens Abuse Prescriptions, Addiction Often Follows
July 29, 2011Long-Term Opioid Therapy Often Leads to Addiction
June 3, 201020% of U.S. High Schoolers Abuse Prescription Drugs
April 6, 2010Tougher-to-Abuse Form of OxyContin Approved
February 18, 2010Oxycontin Abusers Often Rely on 'Leftover' Meds From Friends
Hide
(web2)